Study of Capmatinib Efficacy in Comparison With Docetaxel in Previously Treated Participants With Non-small Cell Lung Cancer Harboring MET Exon 14 Skipping Mutation
Clinical trial NCT04427072 · TERMINATED
Trial details
- NCT number
- NCT04427072
- Sponsor
- Novartis Pharmaceuticals
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-09-25
- Primary completion
- 2023-02-15
- Enrollment
- 22
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.